Table 4.
MMGBSA | MMPBSA | ||||||
---|---|---|---|---|---|---|---|
TLR4-Agonist Vaccine with TLR4 | |||||||
Energy Component | Average | Std Dev | Err. of Mean | Energy Component | Average | Std Dev | Err. of Mean |
Van der Waals Energy | −220.7 | 35.5 | 3.5 | Van der Waals Energy | −220.7 | 35.5 | 3.5 |
Electrostatic Energy | 1798.2 | 82.3 | 8.2 | Electrostatic Energy | 1798.2 | 82.3 | 8.2 |
Gas-Phase Energy | 1577.5 | 55.4 | 5.5 | Gas-Phase Energy | 1577.5 | 55.4 | 5.5 |
Solvation Energy | −1628.4 | 56.6 | 5.66 | Solvation Energy | −1615.3 | 54.0 | 5.4 |
Total | −1628.4 | 13.3 | 1.33 | Total | −37.7 | 15.9 | 1.5 |
β-Defensin Vaccine with TLR4 | |||||||
Van der Waals Energy | −90.2 | 17.1 | 1.7 | Van der Waals Energy | −90.2 | 17.1 | 1.7 |
Electrostatic Energy | 790.7 | 74.6 | 7.4 | Electrostatic Energy | 790.7 | 74.6 | 7.4 |
Gas-Phase Energy | 700.4 | 59.4 | 5.9 | Gas-Phase Energy | 700.4 | 59.4 | 5.9 |
Solvation Energy | −710.29 | 53.6 | 5. | Solvation Energy | −742.8 | 52.5 | 5.2 |
Total | −9.8 | 8.1 | 0.8 | Total | −42.3 | 10.3 | 1.0 |
50S Ribosomal Protein L7/L12 Vaccine with TLR4 | |||||||
Van der Waals Energy | −361.1 | 35.6 | 3.5 | Van der Waals Energy | −361.1 | 35.6 | 3.5 |
Electrostatic Energy | 1723.3 | 52.5 | 5.2 | Electrostatic Energy | 1723.3 | 52.5 | 5.2 |
Gas-Phase Energy | 1362.1 | 45.7 | 4.5 | Gas-Phase Energy | 1362.1 | 45.7 | 4.5 |
Solvation Energy | −1556.8 | 48.6 | 4.8 | Solvation Energy | −1512.8 | 72.3 | 7.2 |
Total | −194.6 | 40.9 | 4.0 | Total | −150.6 | 65.6 | 6.5 |